Floatz logo

SL-28

Intestinal Cancer

Second Life TherapeuticsUNKNOWNPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Intestinal Cancer cohort.

Asset / SponsorPhaseRating
MACROGOLS
Ospedale Santa Maria delle Croci
Phase 4BB
Bisacodyl
Ospedale Santa Maria delle Croci
Phase 4BB
Ciprofol
RenJi Hospital
N/AD

Same molecule, other indications

SL-28 is also rated in:

head and neck cancerActive
CC
Indicative · Phase 1/2
47 / 100
View asset →
malignant pancreatic neoplasmActive
CC
Indicative · Phase 1/2
47 / 100
View asset →
non-small cell lung carcinomaActive
CC
Indicative · Phase 1/2
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →